Etravirine (TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.Etravirine (TMC125), is highly active against wild-type HIV-1 with EC50 of 1.4 nM to 4.8 nM and shows some activity against HIV-2 with EC50 of 3.5 M. TMC125 also inhibits a series of HIV-1 group M subtypes and circulating recombinant forms and a group O virus.
For research use only. We do not sell to patients.